Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
David Jayne, Brad Rovin, Eduardo F Mysler, Richard A Furie, Frederic A Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Yen Lin Chia, Raj Tummala, Catharina Lindholm
Annals of the Rheumatic Diseases Apr 2022, 81 (4) 496-506; DOI: 10.1136/annrheumdis-2021-221478